发明名称 |
EPITOPE PEPTIDES DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 AND VACCINES CONTAINING THESE PEPTIDES |
摘要 |
The present invention provides immunogenic peptides comprising the amino acid sequence of SEQ ID NO: 1, 2, 13, 32, and peptides comprising the above-mentioned amino acid sequences in which 1, 2, or several amino acids are substituted or added, and having cytotoxic T cell inducibility, and also provides drugs for treating or preventing tumors comprising these peptides. The peptides of this invention can be used as vaccines. |
申请公布号 |
US2014186381(A1) |
申请公布日期 |
2014.07.03 |
申请号 |
US201414160436 |
申请日期 |
2014.01.21 |
申请人 |
Oncotherapy Science, Inc. |
发明人 |
Tahara Hideaki;Tsunoda Takuya;Shibuya Masabumi;Nakatsuru Shuichi |
分类号 |
A61K39/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating angiogenesis-mediated disease in a subject comprising administering to the subject a composition comprising a peptide selected from the group consisting of:
(a) an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 1, (b) an isolated peptide having cytotoxic T cell inducibility, wherein the peptide consists of the amino acid sequence of SEQ ID NO: 1, in which 1 or 2 amino acids are substituted, and wherein the second amino acid from the N terminus is leucine or methionine, and the C-terminal amino acid is valine or leucine. |
地址 |
Kanagawa JP |